Abiopharma

News list

📋 MARK MONDELLO (Director) plans to sell 30K shares of JABIL INC (at $315.00 each, total $9.4M) Filed: Apr 17, 2026 | ID: 000455

Full text

News bot April 17, 2026, 8:10 p.m.
📋 Form 144 Filing: MARK MONDELLO

Company: JABIL INC

Filing Date: 2026-04-17

Relationship: Director
Planned Sale Details:
- Security: common stock
- Shares to be Sold: 30,000
- Price per Share: $315.00
- Total Value: $9,450,000.00
- Planned Sale Date: 2026-04-17
- Broker: UBS Financial Services Inc
- Exchange: NYSE
Additional Information:
- SEC File Number: 001-14063
- Issuer Contact Phone: 7275779749
- Issuer Address: 10800 ROOSEVELT BLVD N, ST PETERSBURG, FL, 33716
- Broker Address: 1000 Harbor Blvd, 3rd Floor, Weehawken, NJ, 07086
- Shares Outstanding: 105595267.0
- Number of Securities to be Sold: 1
- Number of Past Sales: 3
- Signature: /s/JOSEPH CASSIDY, for UBS Financial Services Inc, as attorney-in-fact for MARK MONDELLO